Forty Seven's IO Antibody Attracts Two Big Pharma Partners

 
• By Lucie Ellis-Taitt
Cancer-cells-pink-color_1200x675
More cancer combinations: Forty Seven to pair lead compound with PD-L1s

More from Immuno-oncology

More from Anticancer